Linked inTwitter

The 52:52:52 project, launching on this site and on social media in 2025, will help you address 52 issues with 52 responses over 52 weeks.

This site addresses what's changing, at the personal, organisational and societal levels. You'll learn about key changes across more than 150 elements of life, from ageing and time, through nature and animals, to kindness and love...and much more besides, which will help you better prepare for related change in your own life.

Halcyon In Kaleidoscope features irregular and fragmentary writings - on ideas and values, places and people - which evolve over time into mini essais, paying humble homage to the peerless founder of the genre. The kaleidoscope is Halcyon's prime metaphor, viewing the world through ever-moving lenses.

A Mundane Comedy is Dom Kelleher's new book, which will be published in 2025. The introduction is available here and further extracts will appear on this site and on social media in the coming months.

China

What's Changing? - Travel
Travel
Halcyon Identifies 17 August 2024

 

Please see below selected recent travel-related change.

 

See also:

 

August 2024

What's Changing? - Privacy
Privacy
Halcyon Identifies 19 June 2024

 

Please see below selected recent privacy-related change.

 

See also:

 

June 2024

What's Changing? - Belt & Road Initiative
Belt & Road Initiative
Halcyon In Business 7 December 2023

 

Introduction

China's Belt and Road infrastructure initiative is one of the most ambitious geopolitical projects ever. By 2027, it aims to dish out an estimated $1.3 trillion in loans, around ten times what the US spent on the Marshall Plan in the aftermath of World War II. As China increases its investment in the West, will countries' loyalty shift toward Beijing? About 80 countries have already joined, and dozens more are flirting with the idea. For a world that badly needs more and better infrastructure, Belt and Road is a good thing

What's Changing? - Trade
Trade
Halcyon In Business 27 October 2023

 

Please see below key recent developments concerning trade:

 

See also:

 

October 2023

On CRISPR
Genetics
Halcyon In Figures 24 February 2018

 

40%: The percentage of patients reported to have responded to one of the most advanced CRISPR cancer therapy studies to be tested in China. China is far ahead of the US in CRISPR cancer studies due to its less stringent approval requirements, but the US and Europe are set to see their first human trials of the gene-editing technique this year. With potentially transformative implications across medicine, agriculture, and even chemical products, CB Insights' 5,200-word CRISPR deep dive unpacks the science behind the technology, its applications, controversies it’s stirred up, and where CRISPR may take us next. 

Subscribe to China